EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

a diagnosis known as chronic pruritus of unknown origin (CPUO). This itching tends to occur in older adults, and lasts more than six weeks. There have been no treatments for this condition, but a new ...

Eczema, also known as atopic dermatitis, is a chronic skin condition that affects people of all skin types. Here's what you ...

Eczemas in the elderly often arise mysteriously and itch furiously ... studies suggest that patients older than 60 who develop chronic, unexplained eczema are taking more drugs than patients ...

Kayfanda® (odevixibat) approved as new treatment choice for cholestatic pruritus in children from six months with the rare ...

“Patients with uncontrolled chronic spontaneous urticaria experience debilitating itch and hives that appear ... in 151 patients aged six years and older with CSU who remained symptomatic ...

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...

“At a high level, we feel itch when cells in our skin release signaling molecules that activate peripheral nerve fibers that ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved ...

“Patients with uncontrolled chronic spontaneous urticaria experience debilitating itch and hives that appear without warning ... to antihistamines alone in 151 patients aged six years and older with ...

Results from a confirmatory study show that dupilumab significantly reduces itch in patients with uncontrolled chronic spontaneous ... aged 6 years and older were randomly assigned to receive ...